Severe clinical forms of Mediterranean spotted fever: a case series from an endemic area in Bulgaria

Magdalena Baymakova; Liliya  Pekova; Pavlina  Parousheva; Radina  Andonova; Kamen  Plochev

doi:10.2298/VSP160907380B

Magdalena Baymakova Department of Infectious Diseases, Military Medical Academy, Sofia, Bulgaria
Liliya Pekova Department of Infectious Diseases, Stara Zagora, Bulgaria
Pavlina Parousheva Department of Infectious Diseases, Stara Zagora, Bulgaria
Radina Andonova Department of Infectious Diseases, Stara Zagora, Bulgaria
Kamen Plochev Military Medical Academy, Department of Infectious Diseases, Sofia, Bulgaria

DOI: https://doi.org/10.2298/VSP160907380B

Keywords: rickettsia, boutonneuse fever, ticks, bulgaria, serology, blood chemical analyses, diagnosis

Abstract

Abstract

Background/Aim. Mediterranean spotted fever (MSF) belongs to Rickettsioses, the Spotted fever group (SFG). The causal agent is Rickettsia conorii conorii and the transmission to humans occurs through dog tick Rhipicephalus sanguineus bites. The aim of this study was to describe clinical and laboratory characteristics in patients with severe form of Mediterranean spotted fever admitted to Bulgarian university hospital in endemic region. Methods. A retrospective study was conducted at Stara Zagora University Hospital (Southeastern Bulgaria) between April 2015 and August 2016. During the analyzed period, 58 cases had clinical and laboratory data for MSF. Serological tests were applied for the etiological diagnosis. MSF-specific immunoglobulin (IgM) and IgG antibodies were detected in serum by indirect immunoenzyme assay (ELISA IgG/IgM, Vircell, Spain) – R. conorii ELISA IgG sensitivity 85%, specificity 100% and R. conorii ELISA IgM sensitivity 94%, specificity 95%. Statistical analysis was made by MS Excel 2007 and SPSS Statistics, version 19.0. Results. Eighteen patients presented as severe forms. The predominant gender of them were males (78%) and 22% were females. The median age of the analyzed group was 55 years (range: 14–78 years). Ten patients developed hepatic disorder while 4 had neurological signs. Laboratory data showed thrombocytopenia in 15 patients, mean value of platelet (PLT) count for the whole group was 108.6 ± 53.8 × 10⁹/L. Liver enzymes were elevated with mean value of aspartate aminotransferase (AST) 161.4 ± 90.1 IU/L and alanine aminotransferase (ALT) 163.9 ± 81.5 IU/L. Acute phase reactant as C-reactive protein (CRP) had mean value of 140.3 mg/L (range: 9–230 mg/L). Kidney function was impaired in some cases; the mean value of creatinine for the studied group was 134.7 µmol/L (range: 78–313 µmol/L) and mean value of urea was 9.6 mmol/L (range: 4.2–27.4 mmol/L). Conclusion. Bulgaria is an endemic area for tick-borne diseases. Cases of MSF are reported annually. Severe forms of MSF are not rare. Typical clinical and laboratory markers for severity should be actively searched for. Early diagnosis and proper treatment is the key to avoid complications and enable patient recovery.

References

REFERENCES

Raoult D. Introduction to Rickettsioses, Ehrlichioses, and Anaplasmosis. In: Bennett JE, Dolin R, Blaser MJ, editors. Man-dell, Douglas, and Bennett's Principles and practice of infec-tious diseases. 8th ed. Philadelphia (USA): Elsevier Saunders; 2015. p. 2194‒7.

Conor A, Bruch A. Une fièvre éruptive observée en Tu¬nisie. Bull Soc Pathol Exot Filial 1910; 8: 492–6.

Walker DH, Occhino C, Tringali GR, Di Rosa S, Mansueto S. Pa-thogenesis of rickettsial eschars: The tache noire of bouton-neuse fever. Hum Pathol 1988; 19(12): 1449–54.

Pitigoi D, Olaru I, Badescu D, Rafila A, Arama V, Hristea A. Mediterranean spotted fever in southeastern Romania. Biomed Res Int 2013; 2013: 395806.

Baltadzhiev IG, Popivanova NI. Some epidemiological fea¬tures of the Mediterranean spotted fever re-emerging in Bulgaria. Folia Med (Plovdiv) 2012; 54(1): 36–43.

Punda-Polić V, Luksić B, Capkun V. Epidemiological fea¬tures of Mediterranean spotted fever, murine typhus, and Q fever in Split-Dalmatia County (Croatia), 1982-2002. Epidemiol Infect 2008; 136(7): 972–9.

Papa A, Dalla V, Petala A, Maltezou HC, Maltezos E. Fatal Me-diterranean spotted fever in Greece. Clinical microbi¬ology and infection 2010; 16(6): 589–92.

Kuloglu F, Rolain JM, Akata F, Eroglu C, Celik AD, Parola P. Mediterranean spotted fever in the Trakya region of Turkey. Ticks Tick-Borne Dis 2012; 3(5–6): 298–304.

Samardzic S, Marinkovic T, Marinkovic D, Djuricic B, Ris¬tanovic E, Simovic T, et al. Prevalence of antibodies to Rickettsiae in dif-ferent regions of Serbia. Vector Borne Zoonotic Dis 2008; 8(2): 219–24.

Brouqui P, Parola P, Fournier PE, Raoult D. Spotted fever rickettsioses in Southern and Eastern Europe. FEMS Im-munol Med Microbiol 2007; 49(1): 2–12.

Vapzarov I. A small epidemic of Mediterranean spotted fe¬ver in Plovdiv region. Bulgaria. Health Care 1948; 1: 21–9. (Bulgarian)

Serbezov V, Komitova R, Voynova V. Mediterranean spot¬ted fev-er. In: Serbezov V, Kantardjiev T, Krushkov I, edi¬tors. Human tick-borne diseases in Bulgaria. Sofia, BG: East-West; 2003. p. 78–92. (Bulgarian)

Baltadzhiev IG, Popivanova NI, Stoilova YM, Kevorkian AK. Medi-terranean spotted fever: Classification by disease course and criteria for determining the disease severity. Folia Med (Plov-div) 2012; 54(4): 53–61.

Baltadzhiev I. Clinical, epidemiological and pathogenetic as-pects of Mediterranean spotted fever [thesis]. Plovdiv: Faculty of Medicine, University of Plovdiv; 2012. (Bulgar¬ian)

Pishmisheva M, Stoycheva M, Vatev N, Semerdjieva M. Medi-terranean spotted fever in children in the Pazardjik region, South Bulgaria. Pediatr Infect Dis J 2014; 33(5): 542–4.

Baltadzhiev I, Popivanova N, Zaprianov Z. Malignant forms of Mediterranean spotted fever: Risk factors for fatal out¬comes. Braz J Infect Dis 2016; 20(5): 511–2.

Raoult D, Tissot Dupont H, Caraco P, Brouqui P, Drancourt M, et al. Mediterranean spotted fever in Marseille: Descrip¬tive epi-demiology and the influence of climatic factors. Eur J Epide-miol 1992; 8(2): 192–7.

Raoult D, Weiller PJ, Chagnon A, Chaudet H, Gallais H, Casanova P. Mediterranean spotted fever: Clinical, labora¬tory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986; 35(4): 845–50.

Raoult D, Zuchelli P, Weiller P, Charrel C, San Marco J, Gal¬lais H, et al. Incidence, clinical observations and risk fac¬tors in the severe form of Mediterranean spotted fever among patients admitted to the hospital in Marseilles 1983-1984. J Infect 1986; 12(2): 111–6.

Germanakis A, Psaroulaki A, Gikas A, Tselentis Y. Mediterra-nean spotted fever in Crete, Greece: Clinical and therapeutic data of 15 consecutive patients. Ann N Y Acad Sci 2006; 1078: 263–9.

Botelho-Nevers E, Raoult D. Host, pathogen and treatment-related prognostic factors in rickettsioses. Eur J Clin Mi-crobiol Infect Dis 2011; 30(10): 1139–50.

Portillo A, Santibanez S, Garcia-Alvarez L, Palomar AM, Oteo JA. Rickettsioses in Europe. Microb Infect 2015; 17(11–12): 834–8.

Romdhane FB, Loussaief C, Toumi A, Yahia SB, Khaiyrallah M, Bouzouaia N, et al. Mediterranean spotted fever: A re¬port of 200 cases in Tunisia. Clin Microbiol Infect 2009; 15(Suppl 2): 209–10.

Kuloglu F, Akata F, Tansel O, Gurcan S, Sakru N, Otkun M, et al. Serologically confirmed cases of Mediterranean spot¬ted fever in the Trakya region of Turkey. Turk J Parasitol 2004; 28(3): 167–70.

Yilmaz E, Akalin H, Mistik R, Heper Y, Engin A, Kilicaslan E, et al. Mediterranean spotted fever: Retrospective evalua¬tion of 16 cases. Trakya Univ Tip Fak Derg 2010; 27(2): 167–71.

Colomba C, Saporito L, Polara VF, Rubino R, Titone L. Medi-terranean spotted fever: Clinical and laboratory char¬acteristics of 415 Sicilian children. BMC Infect Dis 2006; 6: 60.

Aliaga L, Sanchez-Blazquez P, Rodriguez-Granger J, Sam¬pedro A, Orozco M, Pastor J. Mediterranean spotted fever with encephalitis. J Med Microbiol 2009; 58(4): 521–5.

Tzavella K, Chatzizisis Y, Vakali A, Mandraveli K, Zioutas D, Alexiou-Daniel S. Severe case of Mediterranean spotted fever in Greece with predominantly neurological features. J Med Microbiol 2006; 55(Pt 3): 341–3.